This Biotech Just Catapulted 28%, Flashing A Bullish Sign

expanded its gene therapy collaboration with Voyager Therapeutics (VYGR) on Monday. VYGR stock rocketed above its 200-day line for the first time in four months. The two companies will work together to test gene therapies for Huntington's disease and spinal muscular atrophy. Both inherited…#voyagertherapeutics #huntington #voyager #vygr #marketsmithcom #allisongatlin #ibdagatlin #creamofcrop #3steps #avoidbiglosses
Source: Reuters: Health - Category: Consumer Health News Source Type: news